Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy (CSCR): a Double-blind Randomized Clinical Trial

NCT06809751 is registered in ClinicalTrials.gov with Mohsen Pourazizi as lead sponsor.

NCT NCT06809751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06809751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy (CSCR): a Double-blind Randomized Clinical Trial
Lead sponsor
Mohsen Pourazizi
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
February 1, 2025
Completion date
June 1, 2025
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

central serous chorioretinopathy, macula abnormality, melatonin, ocular diseases, visual acuity